포비돈 요오드 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Povidone Iodine Market size is expected to reach USD 323.22 Million in 2034 from USD 209.79 Million (2025) growing at a CAGR of 4.92% during 2026-2034.

The global povidone iodine market is growing steadily due to its widespread use as an antiseptic and disinfectant in healthcare settings. It is commonly used for wound care, surgical procedures, and infection prevention, making it an essential component in medical practice. The increasing incidence of infections and the rising awareness about hygiene and sanitation are driving market growth. Additionally, the expansion of healthcare facilities and surgical procedures is contributing to the increasing demand for povidone iodine products.

Key growth drivers include the rising focus on infection control and hospital hygiene standards. Povidone iodine is highly effective against a broad spectrum of microorganisms, which enhances its demand in both clinical and homecare applications. The growing pharmaceutical and healthcare industries are further supporting market expansion. Moreover, increased demand during public health emergencies and pandemics has highlighted the importance of antiseptic products, boosting their adoption worldwide.

Looking ahead, the povidone iodine market is expected to witness sustained growth due to ongoing advancements in formulation and product development. Innovations aimed at improving efficacy and reducing skin irritation will enhance product acceptance. Expanding applications in veterinary care and personal hygiene products are likely to create new opportunities. Emerging markets are expected to contribute significantly due to rising healthcare awareness and improving access to medical supplies.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Formulation Type

• Scrub
• Topical Solution
• Ointments
• Others

By Concentration

• 10% Solution
• 7.5% Solution
• Others

By Application

• Skin Sterilization
• Instrument Sterilization
• Disinfectant
• Others

COMPANIES PROFILED

• Avrio Health LP, BASF, 3M, Boai NKY Pharmaceuticals Ltd, Glide Chem Private Limited, RN Laboratories Pvt Ltd, Lasa Supergenerics Limited, Tosoh, Clariant
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL POVIDONE IODINE MARKET: BY FORMULATION TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Formulation Type
• 4.2. Scrub Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Topical Solution Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Ointments Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL POVIDONE IODINE MARKET: BY CONCENTRATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Concentration
• 5.2. 10% Solution Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. 7.5% Solution Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL POVIDONE IODINE MARKET: BY APPLICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. Skin Sterilization Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Instrument Sterilization Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Disinfectant Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL POVIDONE IODINE MARKET: BY REGION 2022-2034 (USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Formulation Type
  • 7.2.2 By Concentration
  • 7.2.3 By Application
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Formulation Type
  • 7.3.2 By Concentration
  • 7.3.3 By Application
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Formulation Type
  • 7.4.2 By Concentration
  • 7.4.3 By Application
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Formulation Type
  • 7.5.2 By Concentration
  • 7.5.3 By Application
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Formulation Type
  • 7.6.2 By Concentration
  • 7.6.3 By Application
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL POVIDONE IODINE INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Avrio Health L.P
  • 9.2.2 BASF
  • 9.2.3 3M
  • 9.2.4 Boai NKY Pharmaceuticals Ltd
  • 9.2.5 Glide Chem Private Limited
  • 9.2.6 R.N Laboratories Pvt. Ltd
  • 9.2.7 Lasa Supergenerics Limited
  • 9.2.8 Tosoh
  • 9.2.9 Clariant